Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
This research peptide blend combines tesamorelin (a stabilized GHRH analog) with ipamorelin (a selective GHS-R1a / ghrelin receptor agonist)
It can currently only be accessed in the UK through approved clinical trials operating under regulatory and ethical oversight
Using this with diet and exercise is a game changer
Our KLOW peptide research compound is handled with strict quality-focused processes to support laboratory research standards
Mechanistically, Ipamorelin binds to the GHS-R1a receptor , mimicking ghrelin to enhance GH secretion
The UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity activity weekly for adults, which aligns well with metabolic health optimisation
US$ 23.83
US$ 20.26
US$ 20.26
US$ 24.83
US$ 20.25
